15
Participants
Start Date
May 5, 2025
Primary Completion Date
May 16, 2025
Study Completion Date
May 27, 2025
INCB123667
single dose administered orally
Celerion, Inc, Lincoln
Lead Sponsor
Incyte Corporation
INDUSTRY